Ann Arbor, MI, AUGUST 10, 2020—Cayman Biomedical Research Institute (CABRI) is now accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted until September 20, 2020 for awards to be distributed by November 2, 2020. Grants range from $2,000 - $5,000 and may be awarded as individual or group grants.

“Because the research positions available to undergraduates do not typically come with a stipend, access to this important experience is limited to students who can afford to work without pay,” said Dr. Kirk Maxey, President and CEO of Cayman and President of CABRI. “Our grant is intended to expand access to this opportunity for more individuals whose early research training will set them on a lifelong path of scientific discovery. Also, we recognize that amid a global pandemic support for these students is even more crucial.”

As a business that provides the products to support essential research for human health and well-being, Cayman is here to help nurture the research community. CABRI is a 501(c)3 nonprofit affiliate of Cayman and is especially dedicated to supporting research for new treatments for rare cancers, orphan diseases, and genetic defects that are typically underfunded. Special consideration will be given to applications from students that work in laboratories aligning with this mission. Undergraduate grant applications may be submitted through this online form.

About Cayman Chemical
Cayman Chemical Company helps make research possible by supplying scientists worldwide with biochemical tools used to understand cancer, neurochemistry, oxidative injury, endocrinology, atherosclerosis, and other human health challenges. Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others for use as research reagents and qualified standards. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination. In addition, Cayman Contract Services provides discovery and pre-clinical development services to the global pharmaceutical, biotechnology, and academic research markets. Our diverse suite of services leverages a team of over 150 highly skilled scientists with expertise in medicinal chemistry, structure-based drug design, complex multi-step organic synthesis, analytical chemistry, sample analysis, and custom assay development. Cayman performs generic drug development and production in both Ann Arbor, Michigan and Neratovice, Czech Republic.

About CABRI
Cayman Biomedical Research Institute (CABRI) is a nonprofit organization which supports research on the rare illnesses and orphan diseases that are often neglected by the corporate pharmaceutical industry and actively pursues new developments that will treat these diseases. To support this endeavor, we offer research grants to specific principal investigators at academic research institutions who have a plan to extend the clinical or pre-clinical development for these diseases as well as undergraduate grants to assist students to obtain experience in laboratories while performing research that aligns with CABRI’s mission. CABRI also provides scholarships to college-bound students who have lost a parent to SNUC (sinonasal undifferentiated carcinoma).